Expert second opinions for multi-valve disease. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Multi-Valve Disease involves significant pathology affecting two or more heart valves simultaneously. If you are facing a decision about multi-valve disease, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Multi-valve disease involves significant pathology affecting two or more heart valves simultaneously. The most common combinations are aortic and mitral valve disease, often with secondary tricuspid regurgitation. Surgical planning for multi-valve disease is more complex than single-valve operations.
Multi-valve operations are longer, more complex, and carry higher risk than single-valve procedures. The decision about which valves to repair vs replace, whether to address the tricuspid valve, and whether a staged or simultaneous approach is optimal requires careful multidisciplinary planning. Risk scores may underestimate actual risk for unusual valve combinations.
Surgery for multi-valve disease depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Multi-valve operations are longer, more complex, and carry higher risk than single-valve procedures. The decision about which valves to repair vs replace, whether to address the tricuspid valve, and whether a staged or simultaneous approach is optimal requires careful multidisciplinary planning. Risk scores may underestimate actual risk for unusual valve combinations.
Operative mortality for multi-valve disease-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for multi-valve disease depends on anatomy, comorbidities, age, and personal goals. Repair vs replacement strategy for each valve. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.